Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Westlab Pharmacy, Inc. dba Westlab Pharmacy
WARNING LETTER
•Westlab Pharmacy, Inc. dba Westlab Pharmacy•August 15, 2018

Westlab Pharmacy, Inc. dba Westlab Pharmacy – FDA Warning Letter, Aug 15, 2018

Record Details

The FDA inspected Westlab Pharmacy, Inc. from August 6-15, 2018, identifying serious deficiencies in sterile drug production and violations of the Federal Food, Drug, and Cosmetic Act (FDCA). The firm failed to meet Section 503A conditions for exemption from CGMP, labeling, and FDA approval, specifically by compounding non-sterile drug products without individually-identified patient prescriptions (e.g., for office stock).

Violations included adulterated drug products due to insanitary conditions: an ISO 5 compounding aseptic containment isolator (CACI) in a non-cleanroom, use of non-sterile cleaning agents/wipes in an ISO 5 laminar airflow workstation (LAFW), exposed hands during aseptic processing, an uncovered light fixture in the ISO 5 area, and continued production in an ISO 5 LAFW after microbial contamination. Additionally, non-pharmaceutical grade components (e.g., drinking alcohol) were used for injectables, and water quality for non-sterile products was not confirmed.

The firm also violated CGMP regulations (21 CFR Parts 210 and 211) by failing to establish written procedures for component handling, conduct final product testing for identity and strength, and support expiration dates with stability testing. These issues render the ineligible drug products adulterated and misbranded under FDCA Sections 501(a)(2)(A), 501(a)(2)(

Company
Westlab Pharmacy, Inc. dba Westlab Pharmacy
Inspection date
August 15, 2018
Product type
Drugs
Office
Office of Pharmaceutical Quality Operations Division I
People
  • Monica R. Maxwell (Program Division Director)
  • Renee Alsobrook
View Company Profile

ID · bf2d5989-34a0-4a44-afd2-da8a05eb0d95

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 351(a)(2)(A)21 U.S.C. 331(k)21 CFR 211.80(a)21 CFR 211.165(a)21 CFR 211.137(a)21 CFR 210

Full citation text and observation details available on the Dashboard.

Other documents for Westlab Pharmacy, Inc. dba Westlab Pharmacy
  • 483 - 2021-10-05October 5, 2021
  • 483 - 2018-08-15August 15, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Westlab Pharmacy, Inc. dba Westlab Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.